Wednesday, Jul 1, 2026 · SEC filings

What the smart money revealed on Jul 1

Real insider buys46insiders · $4.82M
Real insider sales42insiders · $448M
Fund 13Fs filed31quarterly holdings
Activist 13Ds filed05%+ stakes

826 insider filings came in. We hid 109 planned (10b5-1) sellers and 606 people whose filings were routine, like grants and tax withholding.

group

11 insiders at Simon Property Group (SPG) bought $533K of stock

Roles: Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jun 30
$533K
group

3 insiders at Blackstone Private Equity Strategies Fund bought $194K of stock

Roles: Chairperson, President, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jun 29
$194K
group

3 insiders at Polestar Automotive Holding UK (PSNY) bought $178K of stock

Roles: Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jun 29
$178K
trending_up

Rh (RH) Director Carlos Alberini bought $1.83M

11,388 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jun 29
$1.83M
trending_up

First Guaranty Bancshares (FGBI) Director Edgar Smith bought $794K

74,846 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 5 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 5 beat Traded Jun 30
$794K
trending_up

Faeth Therapeutics (FTH) CFO Brian Stephenson bought $326K

13,634 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jun 29–Jul 1
$326K
trending_up

Nuvectis Pharma (NVCT) Chairman & CEO Ron Bentsur bought $250K

12,500 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 5 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 5 beat Traded Jun 30
$250K
account_balance

Confluence Investment Management filed its holdings: 290 stocks

Holdings as of Jun 30, 2026. Open the fund to see what it bought and sold.

13F As of Jun 30
$6.4B
account_balance

Cacti Asset Management filed its holdings: 76 stocks

Holdings as of Jun 30, 2026. Open the fund to see what it bought and sold.

13F As of Jun 30
$1.99B
trending_down

Oruka Therapeutics (ORKA) Director Tomas Kiselak sold $300M

Not marked as a planned 10b5-1 sale. Sold 76% of the shares they held directly. Still holds 1.13M shares.

Real sale Form 4 Sold 76% of stake Traded Jul 1
$300M
trending_down

Alibaba Group Holding (BABA) President J. Evans sold $68.4M

Not marked as a planned 10b5-1 sale. Sold 96% of the shares they held directly. Still holds 28,000 shares.

Real sale Form 4 Sold 96% of stake Traded Jun 29
$68.4M
trending_down

Cerebras Systems (CBRS) COO Dhiraj Mallick sold $2.07M

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jun 30
$2.07M

13F season

Holdings as of Jun 30, 2026 are due Aug 14

8,899 funds have filed so far. 8,900 filed for the quarter before.

Biggest real insider buys this week

Open-market buys by officers and directors, filed in the 7 days up to Jul 1.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist